Blackrock Neurotech Restores ALS Patient's Speech Using Brain-Computer Interface
Blackrock Neurotech has successfully restored speech for an ALS patient through a brain-computer interface (BCI) implant, achieving a communication rate of 62 words per minute. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and loss of voluntary movement, including the ability to speak.
This development showcases an application of Blackrock's Utah Array technology, a system that has been central to the company’s BCI advancements for nearly two decades, enabling applications like thought-to-text conversion and robotic limb control.
See also: Ex-NASA Expert Unveils Everything You Need to Know About Brain-Computer Interfaces
This breakthrough has been supported by Tether, a digital asset company that holds a majority stake in Blackrock Neurotech. Tether’s investment has been critical in driving the research and development efforts necessary for this and other advancements in brain-computer interfaces.
Paolo Ardoino, CEO of Tether, discussed the broader implications of BCI technology:
“While our immediate focus is on medical applications, the future potential of BCI technology could extend into consumer markets. We envision scenarios where people might directly interact with computers, control robotic limbs, or even enhance cognitive functions.”
Ardoino also highlighted the importance of addressing ethical considerations as the technology advances:
“As we push the boundaries of what BCI can achieve, it’s crucial that we prioritize safety, privacy, and openness to ensure these innovations benefit humanity as a whole.
Topics: NeuroTech
